Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yufu Tang

Showing results (81-90 of 91) with videos related to

Pageof 10
Sort By:
Theranostics|July 9, 2019
Gadolinium-Chelated Conjugated Polymer-Based Nanotheranostics for Photoacoustic/Magnetic Resonance/NIR-II Fluorescence Imaging-Guided Cancer Photothermal TherapyXiaoming Hu, Yufu Tang, Yuxuan Hu, et al.
Journal of the American Chemical Society|January 28, 2026
Photoactivatable Oligoelectrolytes Engendering Pyroptotic VesiclesHyeonji Rha, HyoungChul Ham, Yufu Tang, et al.
Frontiers in Medicine|November 1, 2021
Gastrointestinal Bleeding, but Not Other Gastrointestinal Symptoms, Is Associated With Worse Outcomes in COVID-19 PatientsHongxin Chen, Zhenhua Tong, Zhuang Ma, et al.
Therapeutic Advances in Gastroenterology|June 20, 2022
Impact of proton pump inhibitors on the in-hospital outcome of COVID-19 patients: a retrospective studyHaijuan Yao, Hongyu Li, Zhuang Ma, et al.
Medicine|June 9, 2021
Comparison of liver biochemical abnormality between COVID-19 patients with liver cirrhosis versus COVID-19 alone and liver cirrhosis alone: A STROBE observational studyYang An, Zhuang Ma, Xiaozhong Guo, et al.
Advanced Materials (Deerfield Beach, Fla.)|May 1, 2018
Activatable Semiconducting Theranostics: Simultaneous Generation and Ratiometric Photoacoustic Imaging of Reactive Oxygen Species In VivoZhen Yang, Yunlu Dai, Chao Yin, et al.
Signal Transduction and Targeted Therapy|October 5, 2025
Transarterial chemoembolization plus atezolizumab and bevacizumab in patients with intermediate hepatocellular carcinoma: a single-arm, phase 2 trialKang Wang, Jinkai Feng, Hongming Yu, et al.
Ebiomedicine|February 5, 2020
A panel of five plasma proteins for the early diagnosis of hepatitis B virus-related hepatocellular carcinoma in individuals at riskKai Cheng, Jie Shi, Zixin Liu, et al.
Nature Cancer|February 5, 2022
Aldolase B suppresses hepatocellular carcinogenesis by inhibiting G6PD and pentose phosphate pathwaysMin Li, Xuxiao He, Weixing Guo, et al.
Alimentary Pharmacology & Therapeutics|June 23, 2023
Effect of different PD-1 inhibitor combination therapies for unresectable intrahepatic cholangiocarcinomaZhengqing Lei, Weihu Ma, Anfeng Si, et al.
Pageof 10

Showing results (81-90 of 91) with videos related to

Sort By:
Pageof 10
Theranostics|July 9, 2019
Gadolinium-Chelated Conjugated Polymer-Based Nanotheranostics for Photoacoustic/Magnetic Resonance/NIR-II Fluorescence Imaging-Guided Cancer Photothermal TherapyXiaoming Hu, Yufu Tang, Yuxuan Hu, et al.
Journal of the American Chemical Society|January 28, 2026
Photoactivatable Oligoelectrolytes Engendering Pyroptotic VesiclesHyeonji Rha, HyoungChul Ham, Yufu Tang, et al.
Frontiers in Medicine|November 1, 2021
Gastrointestinal Bleeding, but Not Other Gastrointestinal Symptoms, Is Associated With Worse Outcomes in COVID-19 PatientsHongxin Chen, Zhenhua Tong, Zhuang Ma, et al.
Therapeutic Advances in Gastroenterology|June 20, 2022
Impact of proton pump inhibitors on the in-hospital outcome of COVID-19 patients: a retrospective studyHaijuan Yao, Hongyu Li, Zhuang Ma, et al.
Medicine|June 9, 2021
Comparison of liver biochemical abnormality between COVID-19 patients with liver cirrhosis versus COVID-19 alone and liver cirrhosis alone: A STROBE observational studyYang An, Zhuang Ma, Xiaozhong Guo, et al.
Advanced Materials (Deerfield Beach, Fla.)|May 1, 2018
Activatable Semiconducting Theranostics: Simultaneous Generation and Ratiometric Photoacoustic Imaging of Reactive Oxygen Species In VivoZhen Yang, Yunlu Dai, Chao Yin, et al.
Signal Transduction and Targeted Therapy|October 5, 2025
Transarterial chemoembolization plus atezolizumab and bevacizumab in patients with intermediate hepatocellular carcinoma: a single-arm, phase 2 trialKang Wang, Jinkai Feng, Hongming Yu, et al.
Ebiomedicine|February 5, 2020
A panel of five plasma proteins for the early diagnosis of hepatitis B virus-related hepatocellular carcinoma in individuals at riskKai Cheng, Jie Shi, Zixin Liu, et al.
Nature Cancer|February 5, 2022
Aldolase B suppresses hepatocellular carcinogenesis by inhibiting G6PD and pentose phosphate pathwaysMin Li, Xuxiao He, Weixing Guo, et al.
Alimentary Pharmacology & Therapeutics|June 23, 2023
Effect of different PD-1 inhibitor combination therapies for unresectable intrahepatic cholangiocarcinomaZhengqing Lei, Weihu Ma, Anfeng Si, et al.
Pageof 10